Role of angiotensin II in hypertension-induced cardiac hypertrophy and failure

Heart Failure Reviews

Volumn 3, Issue 3, 1999, Pages 159-168

  Csikós, Tamás ^a   Chung, Oliver ^a   Unger, Thomas ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Angiotensin II; Angiotensin receptors; Heart failure; Hypertension; Left ventricular hypertrophy

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR;

CELL GROWTH; HEART FAILURE; HEART HYPERTROPHY; HORMONAL REGULATION; HUMAN; HYPERTENSION; PATHOGENESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0032810536     PISSN: 13824147     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009760014484     Document Type: Review

References (114)

1. Weber KT, Brilla CG. Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991;83(6):1849-1865.
2. Schelling P, Fischer H, Ganten D. Angiotensin and cell growth: a link to cardiovascular hypertrophy? J Hypertens 1991;9(1):3-15.
3. Dudley DT, Panek RL, Major TC, Lu GH, Bruns RF, Klinkefus BA, Hodges JC, Weishaar RE. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol 1990;38(3):370-377.
4. Unger Th, Chung O, Csikós T, Culman J, Gallinat S, Gohlke P, Höhle S, Meffert S, Stoll M, Stroth U, Zhu YZ. Angiotensin receptors. J Hypertens Suppl 1996;14(5):S95-S103.
5. Dzau VJ. Circulating versus local renin-angiotensin system in cardiovascular homeostasis. Circulation 1988;77(6 Pt 2): 14-113.
6. Unger Th, Badoer E, Ganten D, Lang RE and Rettig R. Brain angiotensin: pathways and pharmacology. Circulation 1988;77(Suppl I): 1-40.
7. Rogers TB, Gaa ST, Allen IS. Identification and characterization of functional angiotensin II receptors on cultured heart myocytes. J Pharmacol Exp Ther 1986;236(2):438-444.
8. Mukherjee A, Kulkarni PV, Haghani Z, Sutko JL. Identification and characterization of angiotensin II receptors in cardiac sarcolemma. Biochem Biophys Res Commun 1982; 30;105(2):575-581.
9. Baker KM, Campanile CP, Trachte GJ, Peach MJ. Identification and characterization of the rabbit angiotensin II myocardial receptor. Circ Res 1984;54(3):286-293.
10. Baker KM, Singer HA. Identification and characterization of guinea pig angiotensin II ventricular and atrial receptors: coupling to inositol phosphate production. Circ Res 1988;62 (5):896-904.
11. Rogers TB. High affinity angiotensin II receptors in myocardial sarcolemmal membranes. Characterization of receptors and covalent linkage of 125I-angiotensin II to a membrane component of 116,000 daltons. J Biol Chem 1984;259 (13):8106-8114.
12. Wright GB, Alexander RW, Ekstein LS, Gimbrone MA Jr. Characterization of the rabbit ventricular myocardial receptor for angiotensin II. Evidence for two sites of different affinities and specificities. Mol Pharmacol 1983;24(2):213-221.
13. 2 receptors. Biochem Biophys Res Commun 1991;181 (3):1365-1371.
14. Sechi LA, Griffin CA, Grady EF, Kalinyak JE, Schambelan M. Characterization of angiotensin II receptor subtypes in rat heart. Circ Res 1992;71(6):1482-1489.
15. 1 receptors in the rat heart conduction system. Eur J Pharmacol 1993;235(2-3):301-303.
16. Rogg H, Schmid A, de Gasparo M. Identification and characterization of angiotensin II receptor subtypes in rabbit ventricular myocardium. Biochem Biophys Res Commun 1990;173(1):416-422.
17. Nozawa Y, Haruno A, Oda N, Yamasaki Y, Matsuura N, Yamada S, Inabe K, Kimura R, Suzuki H, Hoshino T. Angiotensin II receptor subtypes in bovine and human ventricular myocardium. J Pharmacol Exp Ther 1994;270(2):566-571.
18. Whitebread S, Mele M, Kamber B, de Gasparo M. Preliminary biochemical characterization of two angiotensin II receptor subtypes. Biochem Biophys Res Commun 1989;163 (1):284-291.
19. Chang RS, Lotti VJ. Angiotensin receptor subtypes in rat, rabbit and monkey tissues: relative distribution and species dependency. Life Sci 1991;49(20):1485-1490.
20. Urata H, Healy B, Stewart RW, Bumpus FM, Husain A. Angiotensin II receptors in normal and failing human hearts. J Clin Endocrinol Metab 1989;69(1):54-66.
21. Regitz-Zagrosek V, Friedel N, Heymann A, Bauer P, Neuss M, Rolfs A, Steffen C, Hildebrandt A, Hetzer R, Fleck E. Regulation, chamber localization, and subtype distribution of angiotensin II receptors in human hearts. Circulation 1995;91(5):1461-1471.
22. Haywood GA, Gullestad L, Katsuya T, Hutchinson HG, Pratt RE, Horiuchi M, Fowler MB. AT1 and AT2 angiotensin receptor gene expression in human heart failure. Circulation 1997;95(5):1201-1206.
23. Rogg H, de Gasparo M, Graedel E, Stulz P, Burkart F, Eberhard M, Erne P. Angiotensin II-receptor subtypes in human atria and evidence for alterations in patients with cardiac dysfunction. Eur Heart J 1996;17(7):1112-1120.
24. de Gasparo M, Rogg H, Brink M, Wang L, Whitebread S, Bullock G, Erne P. Angiotensin II receptor subtypes and cardiac function. Eur Heart J 1994;(Suppl D):98-103.
25. Rogg H, de Gasparo M, Graodel E, Stulz P, Erne P. Identifikation von Angiotensin II Rezeptor Subtypen am Humanen Vorhofgewebe. Schweiz Med Wochenschr 1991;121:23.
26. Brink M, Erne P, de Gasparo M, Rogg H, Schmid A, Stulz P, Bullock GJ. Localization of the angiotensin II receptor subtypes in the human atrium. J Mol Cell Cardiol 1996;28(8): 1789-1799.
27. Neuss M, Regitz-Zagrosek V, Hildebrandt A, Fleck E. Isolation and characterisation of human cardiac fibroblasts from explanted adult hearts. Cell Tissue Res 1996;286(1): 145-153.
28. Regitz-Zagrosek V, Neuss M, Warnecke C, Holzmeister J, Hildebrandt AG, Fleck E. Subtype 2 and atypical angiotensin receptors in the human heart. Basic Res Cardiol 1996;91 (Suppl 2):73-77.
29. Robertson AL Jr, Khairallah PA. Angiotensin II: rapid localization in nuclei of smooth and cardiac muscle. Science 1971; 172(988):1138-1139.
30. Booz GW, Conrad KM, Hess AL, Singer HA, Baker KM. Angiotensin-II-binding sites on hepatocyte nuclei. Endocrinology 1992;130(6):3641-3649.
31. Tang SS, Rogg H, Schumacher R, Dzau VJ. Characterization of nuclear angiotensin-II-binding sites in rat liver and comparison with plasma membrane receptors. Endocrinology 1992;131(1):374-380.
32. Eggena P, Zhu JH, Clegg K, Barrett JD. Nuclear angiotensin receptors induce transcription of renin and angiotensinogen mRNA. Hypertension 1993;22(4):496-501.
33. Asano K, Dutcher DL, Port JD, Minobe WA, Tremmel KD, Roden RL, Bohlmeyer TJ, Bush EW, Jenkin MJ, Abraham WT, Raynolds MV, Zisman LS, Perryman MB, Bristow MR. Selective downregulation of the angiotensin II AT1-receptor subtype in failing human ventricular myocardium. Circulation 1997;95(5):1193-1200.
34. Matsubara H, Kanasaki M, Murasawa S, Tsukaguchi Y, Nio Y, Inada M. Differential gene expression and regulation of angiotensin II receptor subtypes in rat cardiac fibroblasts and cardiomyocytes in culture. J Clin Invest 1994;93(4): 1592-1601.
35. Cheng CP, Suzuki M, Ohte N, Ohno M, Wang ZM, Little WC. Altered ventricular and myocyte response to angiotensin II in pacing-induced heart failure. Circ Res 1996;78(5):880-892.
36. Ohkubo N, Matsubara H, Nozawa Y, Mori Y, Murasawa S, Kijima K, Maruyama K, Masaki H, Tsutumi Y, Shibazaki Y, Iwasaka T, Inada M. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997;96(11):3954-3962.
37. Stoll M, Meffert S, Stroth U, Unger Th. Growth or antigrowth: angiotensin and the endothelium. J Hypertens 1995; 13(12, Pt 2):1529-1534.
38. Saavedra JM. Timmermans PBMWM. Angiotensin II Receptors New York: Plenum Press, 1994.
39. Cockcroft S, Thomas GM. Inositol-lipid-specific phospholipase C isoenzymes and their differential regulation by receptors. Biochem J 1992;288(Pt 1):1-14.
40. Marrero MB, Paxton WG, Duff JL, Berk BC, Bernstein KE. Angiotensin II stimulates tyrosine phosphorylation of phospholipase C-gamma 1 in vascular smooth muscle cells. J Biol Chem 1994;269(14):10935-10939.
41. Marrero MB, Schieffer B, Ma H, Bernstein KE, Ling BN. Ang II-induced tyrosine phosphorylation stimulates phospholipase C-gamma 1 and Cl-channels in mesangial cells. Am J Physiol 1996;270(6, Pt 1):C1834-C1842.
42. Ishida M, Marrero MB, Schieffer B, Ishida T, Bernstein KE, Berk BC. Angiotensin II activates pp60c-src in vascular smooth muscle cells. Circ Res 1995;77(6):1053-1059.
43. Bhat GJ, Thekkumkara TJ, Thomas WG, Conrad KM, Baker KM. Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J Biol Chem 1994;269(50):31443-31449.
44. Marrero MB, Schieffer B, Paxton WG, Heerdt L, Berk BC, Delafontaine P, Bernstein KE. Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor. Nature 1995;375(6528):247-250.
45. Leaman DW, Leung S, Li X, Stark GR. Regulation of STAT-dependent pathways by growth factors and cytokines. FASEB J 1996;10(14):1578-1588.
46. Taubman MB, Berk BC, Izumo S, Tsuda T, Alexander RW, Nadal-Ginard B. Angiotensin II induces c-fos mRNA in aortic smooth muscle. Role of Ca2+ mobilization and protein kinase C activation. J Biol Chem 1989;264(1):526-530.
47. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264(5164): 1415-1421.
48. McWhinney CD, Hunt RA, Conrad KM, Dostal DE, Baker KM. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes. J Mol Cell Cardiol 1997;29(9):2513-2524.
49. Marrero MB, Schieffer B, Li B, Sun J, Harp JB, Ling BN. Role of Janus kinase/signal transducer and activator of transcription and mitogen-activated protein kinase cascades in angiotensin II- and platelet-derived growth factor-induced vascular smooth muscle cell proliferation. J Biol Chem 1997; 272(39):24684-24690.
50. Ali MS, Sayeski PP, Dirksen LB, Hayzer DJ, Marrero MB, Bernstein KE. Dependence on the motif YIPP for the physical association of Jak2 kinase with the intracellular carboxyl tail of the angiotensin II AT1 receptor. J Biol Chem 1997;272 (37):23382-23388.
51. Pan J, Fukuda K, Kodama H, Makino S, Takahashi T, Sano M, Hori S, Ogawa S. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart. Circ Res 1997;81(4):611-617.
52. Yamazaki T, Komuro I, Shiojima I, Yazaki Y. The renin-angiotensin system and cardiac hypertrophy. Heart 1996;76 (3, Suppl 3):33-35.
53. Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature 1988;334(6184):715-718.
54. Ahn NG, Weiel JE, Chan CP, Krebs EG. Identification of multiple epidermal growth factor-stimulated protein serine/threonine kinases from Swiss 3T3 cells. J Biol Chem 1990; 265(20):11487-11494.
55. Kovacina KS, Yonezawa K, Brautigan DL, Tonks NK, Rapp UR, Roth RA. Insulin activates the kinase activity of the Raf-1 proto-oncogene by increasing its serine phosphorylation. J Biol Chem 1990;265(21):12115-12118.
56. Gomez N, Cohen P. Dissection of the protein kinase cascade by which nerve growth factor activates MAP kinases. Nature 1991;353(6340):170-173.
57. Kudoh S, Komuro I, Mizuno T, Yamazaki T, Zou Y, Shiojima I, Takekoshi N, Yazaki Y. Angiotensin II stimulates c-Jun NH2-terminal kinase in cultured cardiac myocytes of neonatal rats. Circ Res 1997;80(1):139-146.
58. Nahmias C, Strosberg AD. The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function. Trends Pharmacol Sci 1995;16(7):223-225.
59. Zhang J, Pratt RE. The AT2 receptor selectively associates with Gialpha2 and Gialpha3 in the rat fetus. J Biol Chem 1996;271(25):15026-15033.
60. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Ungert Th. Angiotensin II AT2 receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 1995;95:651-657.
61. Munzenmaier DH, Greene AS. Opposing actions of angiotensin II on microvascular growth and arterial blood pressure. Hypertension 1996;27(3, Pt2):760-765.
62. Laflamme L, Gasparo M, Gallo JM, Payet MD, Gallo-Payet N. Angiotensin II induction of neurite outgrowth by AT2 receptors in NG108-15 cells. Effect counteracted by the AT1 receptors. J Biol Chem 1996;271(37):22729-22735.
63. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci U S A 1995;92(23):10663-10667.
64. Steckelings UM, Bottari SP, Stoll M, Wagner J, Unger Th. Repression of c-fos and c-jun gene expression is not part of AT2 receptor coupled signal transduction. J Mol Med 1998; 76:202-267.
65. Huang XC, Richards EM, Sumners C. Mitogen-activated protein kinases in rat brain neuronal cultures are activated by angiotensin II type 1 receptors and inhibited by angio tensin II type 2 receptors. J Biol Chem 1996;271(26):15635-15641.
66. Yamada T, Horiuchi M, Dzau VJ. Angiotensin II type 2 receptor mediates programmed cell death. Proc Natl Acad Sci U S A 1996;93(1):156-160.
67. Masaki H, Kurihara T, Yamaki A, Inomata N, Nozawa Y, Mori Y, Murasawa S, Kizima K, Maruyama K, Horiuchi M, Dzau VJ, Takahashi H, Iwasaka T, Inada M, Matsubara H. Cardiacspecific overexpression of angiotensin II AT2 receptor causes attenuated response to AT1 receptor-mediated pressor and chronotropic effects. J Clin Invest 1998;101(3): 527-535.
68. Bedecs K, Elbaz N, Sutren M, Masson M, Susini C, Strosberg AD, Nahmias C. Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase. Biochem J 1997;325(Pt 2):449-454.
69. Hein L, Stevens ME, Barsh GS, Pratt RE, Kobilka BK, Dzau VJ. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A 1997;94(12):6391-6396.
70. Gulick J, Subramaniam A, Neumann J, Robbins J. Isolation and characterization of the mouse cardiac myosin heavy chain genes. J Biol Chem 1991;266(14):9180-9185.
71. Pitt B, Segal R, Martinez FA, Meurers G, Cowley AJ, Thomas I, Deedwania PC, Ney DE, Snavely DB, Chang PI. Randomised trial of losartan versus captopril in patients over 65 with heart failure. Lancet 1997;349(9054):747-752.
72. Oliverio MI, Best CF, Kim HS, Arendshorst WJ, Smithiest O, Coffman TM. Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation. Am J Physiol 1997;272(4, PT2):F515-F520.
73. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK. Behavioral and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 1995;377(6551):744-747.
74. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan Bl, Inagami T. Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 1995;377 (6551):748-750.
75. Niimura F, Labosky PA, Kakuchi J, Okubo S, Yoshida H, Oikawa T, Ichiki T, Naftilan AJ, Fogo A, Inagami T, Hogan B, Ichikawa I. Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J Clin Invest 1995;96(6):2947-2954.
76. Krege JH, John SW, Langenbach LL, Hodgin JB, Hagaman JR, Bachman ES, Jennette JC, O'Brien DA, Smithies O. Male-female differences in fertility and blood pressure in ACE-deficient mice. Nature 1995;375(6527):146-148.
77. Suzuki J, Matsubara H, Urakami M, Inada M. Rat angiotensin II (type 1A) receptor mRNA regulation and subtype expression in myocardial growth and hypertrophy. Circ Res 1993;73(3):439-447.
78. Lopez JJ, Lorell BH, Ingelfinger JR, Weinberg EO, Schunkert H, Diamant D, Tang SS. Distribution and function of cardiac angiotensin AT1-and AT2-receptor subtypes in hypertrophied rat hearts. Am J Physiol 1994;267(2, Pt 2): H844-H852.
79. Campbell-Boswell M, Robertson AL Jr. Effects of angiotensin II and vasopressin on human smooth muscle cells in vitro. Exp Mol Pathol 198;35(2):265-276.
80. Paquet JL, Baudouin-Legros M, Brunelle G, Meyer P. Angiotensin II-induced proliferation of aortic myocytes in spontaneously hypertensive rats. J Hypertens 1990;8(6): 565-572.
81. Stouffer GA, Owens GK. Angiotensin II-induced mitogenesis of spontaneously hypertensive rat-derived cultured smooth muscle cells is dependent on autocrine production of transforming growth factor-beta. Circ Res 1992;70(4):820-828.
82. Geisterfer AA, Peach MJ, Owens GK. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells. Circ Res 1988;62(4):749-756.
83. Berk BC, Vekshtein V, Gordon HM, Tsuda T. Angiotensin II-stimulated protein synthesis in cultured vascular smooth muscle cells. Hypertension 1989;13(4):305-314.
84. + exchange and stimulates growth in cultured vascular smooth muscle cells. J Hypertens Suppl 1988; 6(4):S438-S441.
85. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick heart cells. Am J Physiol 1990;259(2, Pt 2):H610-H618.
86. Aceto JF, Baker KM. [Sar1]angiotensin II receptor-mediated stimulation of protein synthesis in chick heart cells. Am J Physiol 1990;258(3, Pt 2):H806-H813.
87. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993;73(3):413-423.
88. Grady EF, Sechi LA, Griffin CA, Schambelan M, Kalinyak JE. Expression of AT2 receptors in the developing rat fetus. J Clin Invest 1991;88(3):921-933.
89. Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996;28(4):635-640.
90. Metsärinne KP, Stoll M, Gohlke P, Paul M, Unger Th. Angiotensin II is antiproliferative for coronary endothelial cells in vitro. Pharm Pharmacol Lett 1992;2:150-152.
91. van Kesteren CAM, van Heugten HAA, Lamers JMJ, Saxena PR, Schalekamp MADH, Danser AHJ. Angiotensin II-mediated growth and antigrowth effects in cultured neonatal rat cardiac myocytes and fibroblasts. J Mol Cell Cardial 1997;29(8):2147-2157.
92. Sadoshima J, Izumo S. Mechanical stretch rapidly activates multiple signal transduction pathways in cardiac myocytes: potential involvement of an autocrine/paracrine mechanism. EMBO J 1993;12(4):1681-1692.
93. Sadoshima J, Xu Y, Slayter HS, Izumo S. Autocrine release of angiotensin II mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993;75(5):977-984.
94. Brown AJ, Clark SA, Lever AF. Slow rise and diurnal change of blood pressure with saralasin and angiotensin II in rats. Am J Physiol 1983;244(1):F84-F88.
95. Griffin SA, Brown WC, MacPherson F, McGrath JC, Wilson VG, Korsgaard N, Mulvany MJ, Lever AF. Angiotensin II causes vascular hypertrophy in part by a non-pressor mechanism. Hypertension 1991;17(5):626-635.
96. Owens GK, Schwarts SM. Vascular smooth muscle cell hypertrophy and hyperploidy in the Goldblatt hypertensive rat. Circ Res 1983;53(4):491-501.
97. Morishita R, Higaki J, Miyazaki M, Ogihara T. Possible role of the vascular renin-angiotensin system in hypertension and vascular hypertrophy. Hypertension 1992;19(2, Suppl): II62-II67.
98. Linz W, Schölkens BA, Ganten D. Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats. Clin Exp Hypertens [A] 1989;11(7):1325-1350.
99. Baker KM, Chernin MI, Wixson SK, Aceto JF. Renin-angiotensin system involvement in pressure-overload cardiac hypertrophy in rats. Am J Physiol 1990;259(2, Pt 2): H324-H332.
100. Gohlke P, Linz W, Schölkens BA, Van Even P, Martorana P, Unger Th. Vascular and cardiac protection by ramipril in spontaneously hypertensive rats: prevention versus regression study. Br J Clin Pract Suppl 1996;84:1-10.
101. Beinlich CJ, White GJ, Baker KM, Morgan HEJ. Angiotensin II and left ventricular growth in newborn pig heart. Mol Cell Cardiol 1991;23(9):1031-1038.
102. Pfeffer JM, Pfeffer MA, Mirsky I, Braunwald E. Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive rat. Proc Natl Acad Sci U S A 1982;79(10): 3310-3314.
103. Pfeffer MA, Lamas GA, Vaughan DE, Parisi AF, Braunwald E. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. N Engl J Med 1988;319 (2):80-86.
104. Unger Th, Mattfeldt T, Lamberty V, Bock P, Mall G, Linz W. Schölkens BA, Gohlke P. Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries. Hypertension 1992;20(4):478-482.
105. Gohlke P, Stoll M, Lamberty V, Mattfeld T, Mall G, van Even P, Martorana P, Unger Th. Cardiac and vascular effects of chronic angiotensin converting enzyme inhibition at subantihypertensive doses. J Hypertens Suppl 1992;10(6):S141-S144.
106. Gohlke P, Kuwer I, Bartenbach S, Schnell A, Unger Th. Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin. J Cardiovasc Pharmacol 1994;24(3):462-469.
107. Zierhut W, Zimmer HG, Gerdes AM. Effect of angiotensin converting enzyme inhibition on pressure-induced left ventricular hypertrophy in rats. Circ Res 1991;69(3):609-617.
108. Hudlicka O. Growth of capillaries in skeletal and cardiac muscle. Circ Res 1982;50(4):451-461.
109. Gohlke P, Kuwer I, Schnell A, Amann K, Mall G, Unger Th. Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1997;29(1, Pt 2):478-482.
110. Schölkens BA, Linz W, König W. Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist. J Hypertens Suppl 1988;6(4):S25-S28.
111. Gohlke P, Linz W, Schölkens BA, Kuwer I, Bartenbach S, Schnell A, Unger Th. Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 1994;23(4):411-418.
112. Mall G, Zimmer G, Baden S, Mattfeldt T. Capillary neoformation in the rat heart - stereological studies on papillary muscles in hypertrophy and physiologic growth. Basic Res Cardiol 1990;85(6):531-540.
113. Linz W, Jessen T, Becker RH, Schölkens BA, Wiemer G. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997;96(9):3164-3172.
114. Dominiak P, Unger Th. AT1-Rezeptorantagonisten Angiotensin II. Darmstadt: Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG. 1997.